JPMorgan upgraded Arcelik to Overweight from Neutral with a price target of TRY 207, up from TRY 147. The analyst says the worst is almost behind the company. The firm also placed a “Positive Catalyst Watch” on the shares.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>